Yes.
Peers post Ph 2b success:
- PAR - Ph 2b success awaiting Ph 3 trial approval $711.5m MC;
- OPT - Ph 2b success awaiting Ph 3 trial approval $809.9m MC.
Undervalued bios have typically run in the lead up to the phase 2 results. E.g. Paradigm released their Phase 2b data on the 18th of December 2018, the closing share price before the announcement was $1.29. 3-month prior $0.946-month $0.67; and12 month $0.24. BTW 0.24 was $47.7m MC - just to highlight how undervalued we are here. It ran to $200m prior to release.
As for OPT, that was $200m prior to results also - end markets of OPT and PAR are not dissimilar.
Stating the obvious here but,Dimerix currently sits 6 months before not one, but two phase two readouts right now. Should see a rerate over next few months given we are at 19.5m EV (could be up to 10x higher based on peer analysis) and a massive rerate upon success. Crazy risking when you think diabetic subset of ph2a achieved 35% and this trial just needs 30% improvement.
8's.
- Forums
- ASX - By Stock
- Taylor's Initiation
Yes.Peers post Ph 2b success:- PAR - Ph 2b success awaiting Ph 3...
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $184.1M |
Open | High | Low | Value | Volume |
32.0¢ | 34.0¢ | 31.0¢ | $1.526M | 4.675M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24995 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 416229 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24995 | 0.335 |
9 | 790434 | 0.330 |
5 | 1419737 | 0.325 |
3 | 354080 | 0.320 |
5 | 177730 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 416229 | 11 |
0.345 | 543699 | 12 |
0.350 | 944660 | 12 |
0.355 | 277341 | 5 |
0.360 | 446454 | 6 |
Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
Last
33.5¢ |
  |
Change
0.015 ( 4.62 %) |
|||
Open | High | Low | Volume | ||
32.0¢ | 34.0¢ | 31.0¢ | 2395296 | ||
Last updated 15.58pm 02/05/2024 ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online